Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14279/10537
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Charalambous, Andreas | - |
dc.date.accessioned | 2017-11-20T11:54:54Z | - |
dc.date.available | 2017-11-20T11:54:54Z | - |
dc.date.issued | 2017-06-09 | - |
dc.identifier.citation | Asia-Pacific journal of oncology nursing, 2017, vol. 4, no. 3, pp. 220-223 | en_US |
dc.identifier.issn | 23496673 | - |
dc.identifier.uri | https://hdl.handle.net/20.500.14279/10537 | - |
dc.description.abstract | The introduction of targeted therapies in cancer treatment was accompanied with promising results including tumor control and patients survival benefits. However, these drugs just like their predecessors were associated with systemic side effects, including frequent and various cutaneous effects. Targeted therapies such as epidermal growth factor receptor, vascular endothelial growth factor receptor, kit, platelet-derived growth factor receptor, and BCR-ABL inhibitors as well as mammalian target of rapamycin inhibitors can induce cutaneous toxicities of varying severity. There are scarce studies on the actual impact of these toxicities on the patients' lives including the physical, social, and psychological aspects and overall quality of life. Patient's perspective in living with and beyond these toxicities remains largely uncharted but essential in optimizing care provided to those receiving treatment with targeted therapies. | en_US |
dc.format | en_US | |
dc.language.iso | en | en_US |
dc.relation.ispartof | Asia-Pacific Journal of Oncology Nursing | en_US |
dc.rights | © Ann & Joshua Medical Publishing | en_US |
dc.subject | Cutaneous toxicities | en_US |
dc.subject | Quality of life | en_US |
dc.subject | Targeted therapies | en_US |
dc.title | Living with the Effects of Cutaneous Toxicities Induced by Treatment | en_US |
dc.type | Article | en_US |
dc.collaboration | Cyprus University of Technology | en_US |
dc.collaboration | University of Turku | en_US |
dc.subject.category | Other Medical Sciences | en_US |
dc.journals | Subscription | en_US |
dc.country | Cyprus | en_US |
dc.country | Finland | en_US |
dc.subject.field | Medical and Health Sciences | en_US |
dc.publication | Peer Reviewed | en_US |
dc.identifier.doi | 10.4103/2347-5625.207729 | en_US |
dc.relation.issue | 3 | en_US |
dc.relation.volume | 4 | en_US |
cut.common.academicyear | 2016-2017 | en_US |
dc.identifier.spage | 220 | en_US |
dc.identifier.epage | 223 | en_US |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | article | - |
item.languageiso639-1 | en | - |
crisitem.journal.journalissn | 2349-6673 | - |
crisitem.journal.publisher | Medknow Publications | - |
crisitem.author.dept | Department of Nursing | - |
crisitem.author.faculty | Faculty of Health Sciences | - |
crisitem.author.orcid | 0000-0003-4050-031X | - |
crisitem.author.parentorg | Faculty of Health Sciences | - |
Appears in Collections: | Άρθρα/Articles |
CORE Recommender
Page view(s) 50
345
Last Week
2
2
Last month
8
8
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.